U.S. equity markets rallied Monday as two COVID-19 vaccines were given “fast-track” status and earnings season kicked off with some better-than-expected results. Pfizer Inc. and BioNTech SE received fast-track designation for two of their experimental COVID-19 vaccines, helping offset news that the number of new daily COVID-19 infections in the U.S. remained above 60,000 all weekend.
